A cefoxitin-susceptible Staphylococcus aureus strain was identified by the Cepheid GeneXpert as methicillinresistant S. aureus (MRSA). This strain was highly unstable and rapidly lost SCCmec upon subculturing in vitro, indicating that unstable MRSA is best detected by gene amplification-based methods.
A 62-year-old woman underwent posterior lumbar decompression and stabilization L3 to L5 for intractable lumbar pain and neurogenic claudication due to severe stenosis and instability. One month after surgery, the patient experienced progressive lumbar pain; the wound area showed signs of inflammation without purulent secretion. The C-reactive protein (CRP) level was elevated to 98 mg/dl, and body temperature was elevated up to 40°C. Computer tomography showed correct decompression and placement of transpedicular screws and intervertebral cages, with no signs of loosening or abscess formation. A postoperative superficial and potentially deep wound infection was diagnosed. Blood cultures were taken, and empirical intravenous antibiotic therapy with vancomycin, flucloxacillin, and rifampin was administered for 4 days. Fever subsided, blood cultures became positive for Staphylococcus aureus, and intravenous therapy was continued with only flucloxacillin and rifampin for 13 days. The patient was then discharged with levofloxacin and rifampin per os, which was continued for a total of 6 weeks. The CRP level normalized 3 weeks after initial antibiotic treatment, and local pain subsided within 2 months. Further follow-up over 1 year with CRP and clinical and radiological controls was uneventful, and the patient fared well.
The initial S. aureus isolate appeared to be susceptible to methicillin, with an oxacillin MIC of 0.38 mg/liter, as tested by Etest (bioMérieux). The Xpert MRSA (GeneXpert system; Cepheid) performed according to Rossney et al. (17) , however, identified a methicillin-resistant S. aureus (MRSA) strain. The presence of the mecA gene was confirmed by a separate specific PCR amplification used as a control in SCCmec typing (14; data not shown). In addition, the strain showed very weak, inconclusive PBP2a production by latex agglutination upon ␤-lactam induction (MRSA-Screen; Denka Seiken Co., Ltd., Tokyo, Japan) (16). Such extremely-low-level methicillin resistance can occasionally occur in community MRSA (cMRSA) strains (12) , although PBP2a agglutination remains positive, despite low-level resistance.
The MRSA phenotype was extremely unstable, and the mecA gene was rapidly lost upon storage on either blood agar plates at 4°C or in skim milk at Ϫ80°C. Several attempts to rescue and enrich the MRSA phenotype from the stock culture or from agar plates, using selective media containing increasing concentrations of oxacillin or cefoxitin, failed. Fractionation of the original culture after storage on blood agar plates revealed that it produced colonies varying in color and intensity of hemolysis. Six single subclones representing different morphotypes were subcultured and analyzed further (Fig. 1) . All subclones were spa type t012 and produced a penicillinase leading to ampicillin resistance, but were otherwise fully susceptible to other classes of antibiotics tested, including amikacin, amoxicillin-clavulanate, cefoxitin, chloramphenicol, ciprofloxacin, clindamycin, erythromycin, fusidic acid, gentamicin, levofloxacin, oxacillin, rifampin, teicoplanin, tetracycline, tobramycin, and trimethoprim-sulfamethoxazole (determined by disk diffusion according to the recommendation of CLSI [3] ). However, subclone 4 produced rifampin-resistant variants in the rifampin inhibition zone. Subclone 4 also differed in its whole-genome SmaI pulsed-field gel electrophoresis (PFGE) pattern, with the SmaI-E band larger than in the other subclones tested, now migrating close to band D (Fig. 1B) . The larger band E was present in both the rifampin-resistant variant and the original subclone 4. None of the six subclones produced PBP2a by the agglutination test. SCCmec and ccr typing including strains with SCCmec types I to IV as controls (1, 5, 10, 13) showed that only subclone 3 amplified faint mecA, Tn544-orfX, and ccrC fragments, suggesting that it contained remnants of an SCCmec type III-like element. However, only a small subpopulation of subclone 3 must have been carrying SCCmec, since we were unable to visualize a mecA-containing band by Southern blotting of HindIII-digested chromosomal DNA (data not shown), nor was there a visible difference in the chromosomal SmaI PFGE restriction pattern compared to that of the other subclones. No viable MRSA phenotype could be rescued from subclone 3 either. Genomic sequencing starting at the 3Ј end of orfX revealed that each of the six subclones contained identical nucleotide sequences within the orfX region and none had any SCCmec-specific DNA integrated. All subclones were negative when retested with GeneXpert (17) , suggesting that the subpopulation within subclone 3 carrying the SCCmec remnants was below the detection limit. All sub-clones were closely related despite the slightly larger SmaI-E band of subclone 4, differences in the frequency of rifampin resistance formation, and variability in colony morphotype.
The variants were very likely to have evolved due to rearrangements arising during storage. Nonhemolytic variants within S. aureus are known to occur under laboratory and clinical conditions. They can arise by slipped mispairing, a replication error in the agr operon, which also controls hemolysin production. Loss of methicillin resistance from clinical isolates has been reported previously, and instability of the SCCmec element in specific strains has been described (4, 7). It is also known that the genetic background of a strain can determine the stability of SCCmec in S. aureus (11) . Certain MRSA strains seem to be more prone to losing SCCmec or the mecA gene upon storage (6, 7, 9, 19) . Isolates without the mecA gene but positive by Xpert MRSA have previously been described (18) , but in this isolate, the GeneXpert test also became negative after storage, as did the mecA-specific PCR.
The very weak PBP2a agglutination in the initial culture, which is unusual even for low-level-resistant cMRSA, suggested that the majority of the bacteria in the original sample must have had already lost mecA and that the proportion still producing PBP2a was just above detection levels. Nevertheless, the low oxacillin MIC may also be due to the strain's genetic background as some MRSA strains, especially cMRSA isolates, express very-low-level resistance. The SCCmec type of the original MRSA could not be deduced, but was probably similar to type III. The SCCmec element is a dynamic structure and undergoes rearrangements, insertions, and deletions, creating new combinations and types of SCCmec (2, 8, 15, 20) . Mutations, rearrangements, and deletions including the mecA gene or the site-specific excision of the entire element can lead to oxacillin susceptibility. Some strains may be unstable for various reasons, such as fitness loss following acquisition of the MRSA phenotype or incompatibility of mecA or PBP2a with certain genetic backgrounds.
PCR screening clearly facilitates the detection of unstable isolates, and direct screening of MRSA with the GeneXpert system minimizes additional selection pressure leading to the loss of SCCmec by subculturing. Resistance testing should be performed as soon as possible to prevent the loss of resistance determinants or phenotypes. The clinical relevance of MRSA strains that are unstable in vitro remains unknown, as does their stability in vivo. In this case, the patient recovered well, and combination therapy eradicated the pathogen.
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